A 42-year-old woman with diabetic ketoacidosis (pH 7.15, HCO₃⁻ 10 mEq/L, anion gap 18, glucose 520 mg/dL, serum K⁺ 5.2 mEq/L) is admitted to the ICU. After initiation of IV fluids and insulin infusion, what is the drug of choice for acute correction of severe metabolic acidosis?

Explanation

## Acute Management of Severe Metabolic Acidosis in DKA ### Pathophysiology of DKA Acidosis DKA causes severe metabolic acidosis via: - Uncontrolled lipolysis → free fatty acid oxidation → ketone body accumulation (β-hydroxybutyrate, acetoacetate) - High anion gap metabolic acidosis (anion gap = 18 in this case) - Severe acidemia (pH < 7.2) impairs cardiac contractility and catecholamine responsiveness ### Acute vs. Chronic Acidosis Management | Scenario | pH | Anion Gap | First-Line Agent | Rationale | |----------|-----|-----------|------------------|----------| | **DKA (acute, severe)** | < 7.15 | High (>12) | **Sodium bicarbonate 8.4%** | Rapid pH correction prevents cardiovascular collapse; insulin + fluids address underlying ketosis | | **CKD (chronic, normal AG)** | 7.25–7.35 | Normal | **Potassium citrate** | Slow correction; K⁺ supplementation needed; Na⁺ load contraindicated | | **Lactic acidosis** | < 7.2 | High | **Sodium bicarbonate** (if pH < 7.1) | Supportive; treat underlying cause (sepsis, hypoxia) | ### Key Point: When to Use Sodium Bicarbonate in DKA **High-Yield:** Sodium bicarbonate is indicated in DKA ONLY when: 1. **pH < 7.15** (severe acidemia causing hemodynamic instability) 2. **Anion gap > 12** (confirms high AG metabolic acidosis) 3. **Concurrent insulin + fluid therapy** is already initiated (bicarbonate alone does not treat ketosis) **Clinical Pearl:** The traditional teaching was to avoid bicarbonate in DKA due to risk of paradoxical CSF acidosis and hypokalemia. However, current evidence supports cautious use of 8.4% sodium bicarbonate (1–2 amps in 200 mL 5% dextrose over 1–2 hours) when pH < 7.15 to prevent arrhythmias and cardiogenic shock. ### Dosing of Sodium Bicarbonate in DKA - **Concentration:** 8.4% (1 mEq/mL) or 7.5% (0.9 mEq/mL) - **Dose:** 50–100 mEq IV over 1–2 hours (repeat every 2–4 hours if pH remains < 7.15) - **Target:** pH ≥ 7.20 (not full correction; insulin + fluids will continue to improve pH) - **Monitoring:** Recheck ABG every 2–4 hours; monitor K⁺ closely (bicarbonate shifts K⁺ intracellularly, worsening hypokalemia) ### Why Insulin + Fluids Are Not Sufficient Alone While insulin and IV fluids are the cornerstone of DKA management: - Insulin suppresses ketogenesis and promotes ketone utilization (takes 4–6 hours for significant effect) - Fluids dilute ketones and improve renal perfusion - In severe acidemia (pH < 7.15), these measures may not prevent acute cardiovascular decompensation; bicarbonate provides bridge therapy **Warning:** Do NOT use bicarbonate as monotherapy; it does not address the underlying ketosis. Always pair with insulin infusion (0.1 U/kg/hr) and isotonic saline (1 L/hr initially). [cite:Harrison 21e Ch 397]